230 related articles for article (PubMed ID: 33002568)
21. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
[TBL] [Abstract][Full Text] [Related]
22. Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review.
Zafirovska M; Zafirovski A; Rotovnik Kozjek N
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513587
[TBL] [Abstract][Full Text] [Related]
23. A nordic multicenter study on contemporary outcomes of pediatric short bowel syndrome in 208 patients.
Mutanen A; Engstrand Lilja H; Wester T; Norrby H; Borg H; Persson S; Bjornland K; Brun AC; Telborn L; Stenström P; Pakarinen MP
Clin Nutr; 2023 Jul; 42(7):1095-1103. PubMed ID: 37270343
[TBL] [Abstract][Full Text] [Related]
24. Abnormal distribution of fat tissue and its association with intestinal failure-associated liver disease in children and adolescents with long-time parenteral nutrition support: A case-control study.
Takahashi N; Kato M; Yamada Y; Tsujikawa H; Irie R; Okabayashi K; Kitagawa Y; Kuroda T
JPEN J Parenter Enteral Nutr; 2023 Sep; 47(7):938-946. PubMed ID: 37416985
[TBL] [Abstract][Full Text] [Related]
25. The gut microbiome and intestinal failure-associated liver disease.
Jiang L; Xu J; Cheng SY; Wang Y; Cai W
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):452-457. PubMed ID: 37453856
[TBL] [Abstract][Full Text] [Related]
26. Review article: diagnosis and management of intestinal failure-associated liver disease in adults.
Bond A; Huijbers A; Pironi L; Schneider SM; Wanten G; Lal S
Aliment Pharmacol Ther; 2019 Sep; 50(6):640-653. PubMed ID: 31342540
[TBL] [Abstract][Full Text] [Related]
27. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.
Fousekis FS; Mitselos IV; Christodoulou DK
Saudi J Gastroenterol; 2021; 27(1):3-12. PubMed ID: 33642350
[TBL] [Abstract][Full Text] [Related]
28. Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.
Mihajlovic M; Rosseel Z; De Waele E; Vinken M
Toxicol Sci; 2024 Apr; 199(1):1-11. PubMed ID: 38383052
[TBL] [Abstract][Full Text] [Related]
29. Systematic Review: Noninvasive Assessments of Intestinal Failure-Associated Liver Disease in the Adult Population.
Huijbers A; Koggel LM; Bronkhorst C; Verheij J; Wanten GJA
JPEN J Parenter Enteral Nutr; 2019 Jul; 43(5):615-626. PubMed ID: 30937931
[TBL] [Abstract][Full Text] [Related]
30. A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
Fligor SC; Tsikis ST; Hirsch TI; Pan A; Moskowitzova K; Rincon-Cruz L; Whitlock AE; Mitchell PD; Nedder AP; Gura KM; Fraser DA; Puder M
Gastroenterology; 2023 Sep; 165(3):733-745.e9. PubMed ID: 37263310
[TBL] [Abstract][Full Text] [Related]
31. Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure.
Mutanen A; Lohi J; Heikkilä P; Koivusalo AI; Rintala RJ; Pakarinen MP
Hepatology; 2013 Aug; 58(2):729-38. PubMed ID: 23460496
[TBL] [Abstract][Full Text] [Related]
32. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure.
Mutanen A; Lohi J; Heikkilä P; Jalanko H; Pakarinen MP
J Hepatol; 2015 Jun; 62(6):1391-7. PubMed ID: 25595885
[TBL] [Abstract][Full Text] [Related]
33. Long-term assessment of bilirubin and transaminase trends in pediatric intestinal failure patients during the era of hepatoprotective parenteral nutrition.
Keefe G; Culbreath K; Knell J; Chugh PV; Staffa SJ; Jaksic T; Modi BP
J Pediatr Surg; 2022 Jan; 57(1):122-126. PubMed ID: 34686375
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA 122 Reflects Liver Injury in Children with Intestinal Failure-Associated Liver Disease Treated with Intravenous Fish Oil.
Calkins KL; Thamotharan S; Ghosh S; Dai Y; Devaskar SU
J Nutr; 2020 May; 150(5):1144-1150. PubMed ID: 32072161
[TBL] [Abstract][Full Text] [Related]
35. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
Khalaf RT; Sokol RJ
Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Children With Chronic Intestinal Failure: Experience Over 2 Decades at a Tertiary Paediatric Hospital.
Jo SC; McCallum Z; Shalley H; Peterkin M; Rogers E; Paxton G; Wong T; Bines JE
J Pediatr Gastroenterol Nutr; 2019 Sep; 69(3):e79-e87. PubMed ID: 31169663
[TBL] [Abstract][Full Text] [Related]
37. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury.
Hukkinen M; Mutanen A; Pakarinen MP
Surgery; 2017 Sep; 162(3):670-679. PubMed ID: 28689603
[TBL] [Abstract][Full Text] [Related]
38. Liver Inflammation Relates to Decreased Canalicular Bile Transporter Expression in Pediatric Onset Intestinal Failure.
Mutanen A; Lohi J; Heikkilä P; Jalanko H; Pakarinen MP
Ann Surg; 2018 Aug; 268(2):332-339. PubMed ID: 28234635
[TBL] [Abstract][Full Text] [Related]
39. Twelve-year outcomes of intestinal failure-associated liver disease in children with short-bowel syndrome: 97% transplant-free survival and 81% enteral autonomy.
Torres C; Badalyan V; Mohan P
JPEN J Parenter Enteral Nutr; 2022 Jan; 46(1):197-206. PubMed ID: 33794031
[TBL] [Abstract][Full Text] [Related]
40. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
